Research note

Perspectives on the hierarchy of HIV and hepatitis C disease: Consequences for drug treatment program patients

Corrine Munoz-Plaza, Shiela M. Strauss, Nelson Tiburcio, Janetta M. Astone-Twerell, Don Des Jarlais, Marya Gwadz, Holly Hagan, Andrew Osborne, Andrew Rosenblum

Research output: Contribution to journalArticle

Abstract

Injection drug users (IDUs) face an increased risk of acquiring blood borne viral infections, including HIV and the hepatitis C virus (HCV). However, the discrepancy in funding for services to address these two diseases has implications. Although drug treatment programs have played an important role in fighting HIV/AIDS, the HCV-related services offered at these programs remain limited. Research from other countries suggests that drug users view HCV as less important than HIV, yet little is known about the extent to which our society's focus on HIV has been adopted within the drug treatment program culture. This qualitative study examines the perceptions of both staff (n = 165) and clients (n = 215) at these programs with regard to HIV and HCV and presents data on how staffs' attitudes toward HCV changed after participating in an HCV training. Clients described a services landscape at drug treatment programs that favors HIV services over those targeting HCV.

Original languageEnglish (US)
Pages (from-to)517-536
Number of pages20
JournalJournal of Drug Issues
Volume40
Issue number2
StatePublished - Mar 2010

Fingerprint

Hepatitis C
Hepacivirus
contagious disease
HIV
drug
Disease
Research
Pharmaceutical Preparations
Drug Users
Therapeutics
Attitude of Health Personnel
staff
Virus Diseases
Acquired Immunodeficiency Syndrome
AIDS
funding
Injections
society

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Public Health, Environmental and Occupational Health
  • Medicine (miscellaneous)
  • Health(social science)

Cite this

Research note : Perspectives on the hierarchy of HIV and hepatitis C disease: Consequences for drug treatment program patients. / Munoz-Plaza, Corrine; Strauss, Shiela M.; Tiburcio, Nelson; Astone-Twerell, Janetta M.; Des Jarlais, Don; Gwadz, Marya; Hagan, Holly; Osborne, Andrew; Rosenblum, Andrew.

In: Journal of Drug Issues, Vol. 40, No. 2, 03.2010, p. 517-536.

Research output: Contribution to journalArticle

Munoz-Plaza, C, Strauss, SM, Tiburcio, N, Astone-Twerell, JM, Des Jarlais, D, Gwadz, M, Hagan, H, Osborne, A & Rosenblum, A 2010, 'Research note: Perspectives on the hierarchy of HIV and hepatitis C disease: Consequences for drug treatment program patients', Journal of Drug Issues, vol. 40, no. 2, pp. 517-536.
Munoz-Plaza, Corrine ; Strauss, Shiela M. ; Tiburcio, Nelson ; Astone-Twerell, Janetta M. ; Des Jarlais, Don ; Gwadz, Marya ; Hagan, Holly ; Osborne, Andrew ; Rosenblum, Andrew. / Research note : Perspectives on the hierarchy of HIV and hepatitis C disease: Consequences for drug treatment program patients. In: Journal of Drug Issues. 2010 ; Vol. 40, No. 2. pp. 517-536.
@article{bda2b299286746938877c2cd3a0863c3,
title = "Research note: Perspectives on the hierarchy of HIV and hepatitis C disease: Consequences for drug treatment program patients",
abstract = "Injection drug users (IDUs) face an increased risk of acquiring blood borne viral infections, including HIV and the hepatitis C virus (HCV). However, the discrepancy in funding for services to address these two diseases has implications. Although drug treatment programs have played an important role in fighting HIV/AIDS, the HCV-related services offered at these programs remain limited. Research from other countries suggests that drug users view HCV as less important than HIV, yet little is known about the extent to which our society's focus on HIV has been adopted within the drug treatment program culture. This qualitative study examines the perceptions of both staff (n = 165) and clients (n = 215) at these programs with regard to HIV and HCV and presents data on how staffs' attitudes toward HCV changed after participating in an HCV training. Clients described a services landscape at drug treatment programs that favors HIV services over those targeting HCV.",
author = "Corrine Munoz-Plaza and Strauss, {Shiela M.} and Nelson Tiburcio and Astone-Twerell, {Janetta M.} and {Des Jarlais}, Don and Marya Gwadz and Holly Hagan and Andrew Osborne and Andrew Rosenblum",
year = "2010",
month = "3",
language = "English (US)",
volume = "40",
pages = "517--536",
journal = "Journal of Drug Issues",
issn = "0022-0426",
publisher = "Journal of Drug Issues Inc.",
number = "2",

}

TY - JOUR

T1 - Research note

T2 - Perspectives on the hierarchy of HIV and hepatitis C disease: Consequences for drug treatment program patients

AU - Munoz-Plaza, Corrine

AU - Strauss, Shiela M.

AU - Tiburcio, Nelson

AU - Astone-Twerell, Janetta M.

AU - Des Jarlais, Don

AU - Gwadz, Marya

AU - Hagan, Holly

AU - Osborne, Andrew

AU - Rosenblum, Andrew

PY - 2010/3

Y1 - 2010/3

N2 - Injection drug users (IDUs) face an increased risk of acquiring blood borne viral infections, including HIV and the hepatitis C virus (HCV). However, the discrepancy in funding for services to address these two diseases has implications. Although drug treatment programs have played an important role in fighting HIV/AIDS, the HCV-related services offered at these programs remain limited. Research from other countries suggests that drug users view HCV as less important than HIV, yet little is known about the extent to which our society's focus on HIV has been adopted within the drug treatment program culture. This qualitative study examines the perceptions of both staff (n = 165) and clients (n = 215) at these programs with regard to HIV and HCV and presents data on how staffs' attitudes toward HCV changed after participating in an HCV training. Clients described a services landscape at drug treatment programs that favors HIV services over those targeting HCV.

AB - Injection drug users (IDUs) face an increased risk of acquiring blood borne viral infections, including HIV and the hepatitis C virus (HCV). However, the discrepancy in funding for services to address these two diseases has implications. Although drug treatment programs have played an important role in fighting HIV/AIDS, the HCV-related services offered at these programs remain limited. Research from other countries suggests that drug users view HCV as less important than HIV, yet little is known about the extent to which our society's focus on HIV has been adopted within the drug treatment program culture. This qualitative study examines the perceptions of both staff (n = 165) and clients (n = 215) at these programs with regard to HIV and HCV and presents data on how staffs' attitudes toward HCV changed after participating in an HCV training. Clients described a services landscape at drug treatment programs that favors HIV services over those targeting HCV.

UR - http://www.scopus.com/inward/record.url?scp=77956086837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956086837&partnerID=8YFLogxK

M3 - Article

VL - 40

SP - 517

EP - 536

JO - Journal of Drug Issues

JF - Journal of Drug Issues

SN - 0022-0426

IS - 2

ER -